MiNK Therapeutics, Inc. Common Stock (INKT) News
Latest headlines that mention INKT, newest first · each headline opens the original publisher
- Last price
- $10.43
- Day change
- -2.61%
- Next earnings
- 2026-11-13
INKT headlines
latest coverageNet loss narrowed to $3.1 million as Phase 2 trial for agenT-797 advances in Ukraine.
Image source: The Motley Fool. Tuesday, March 31, 2026 at 5:30 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading
Image source: The Motley Fool. Friday, May 15, 2026 at 8:30 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading
INKT news alerts
Get an alert by email or push when a new headline mentions INKT.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.